Home >> Marketplace Archives >> Rapid Zika virus diagnostic, 6/16

Rapid Zika virus diagnostic, 6/16

Print Friendly, PDF & Email


June 2016—Rheonix, in collaboration with New York University College of Dentistry, has received funding from a Small Business Innovation Research Phase I/II Fast-track grant from the National Institute of Dental and Craniofacial Research of the National Institutes of Health to develop a rapid diagnostic for Zika virus infection. The grant will allow the Rheonix/NYUCD team to pursue the development of a fully automated screening and self-confirming assay that will simultaneously detect and confirm the presence of Zika virus in a single, small sample of saliva or blood.

The assay will be performed on the Rheonix Chemistry and Reagent Device or Rheonix CARD cartridge interfaced with the Encompass Optimum workstation.

Rheonix, 607-257-1242


Check Also

RUO molecular platform, 7/15

July 2015—Rheonix showcased in June its Encompass Optimum research-use-only platform at the 115th General Meeting of the American Society for Microbiology. The Encompass Optimum is an automated system for building and implementing molecular assays as a nonclinical tool.